38182581|t|Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
38182581|a|Breakdown of the neurovascular unit is associated with blood-brain barrier (BBB) leakiness contributing to cognitive decline and disease pathology in the early stages of Alzheimer's disease (AD). Vascular stability depends on angiopoietin-1 (ANGPT-1) signalling, antagonised by angiopoietin-2 (ANGPT-2) expressed upon endothelial injury. We examined the relationship between CSF ANGPT-2 and CSF markers of BBB leakiness and core AD biomarkers across three independent cohorts: (i) 31 AD patients and 33 healthy controls grouped according to their biomarker profile (i.e., AD cases t-tau > 400 pg/mL, p-tau > 60 pg/mL and Abeta42 < 550 pg/mL); (ii) 121 participants in the Wisconsin Registry for Alzheimer's Prevention or Wisconsin Alzheimer's Disease Research study (84 participants cognitively unimpaired (CU) enriched for a parental history of AD, 20 participants with mild cognitive impairment (MCI), and 17 with AD); (iii) a neurologically normal cohort aged 23-78 years with paired CSF and serum samples. CSF ANGPT-2, sPDGFRbeta, albumin and fibrinogen levels were measured by sandwich ELISA. In cohort (i), CSF ANGPT-2 was elevated in AD and correlated with CSF t-tau and p-tau181 but not Abeta42. ANGPT-2 also correlated positively with CSF sPDGFRbeta and fibrinogen - markers of pericyte injury and BBB leakiness. In cohort (ii), CSF ANGPT-2 was highest in MCI and correlated with CSF albumin in the CU and MCI cohorts but not in AD. CSF ANGPT-2 also correlated with CSF t-tau and p-tau and with markers of neuronal injury (neurogranin and alpha-synuclein) and neuroinflammation (GFAP and YKL-40). In cohort (iii), CSF ANGPT-2 correlated strongly with the CSF/serum albumin ratio. Serum ANGPT-2 showed non-significant positive associations with CSF ANGPT-2 and the CSF/serum albumin ratio. Together, these data indicate that CSF and possibly serum ANGPT-2 is associated with BBB leakiness in early AD and is closely related to tau pathology and neuronal injury. The utility of serum ANGPT-2 as a biomarker of BBB damage in AD requires further study.
38182581	13	27	angiopoietin-2	Gene	285
38182581	89	104	neuronal injury	Disease	MESH:D009410
38182581	114	133	Alzheimer's disease	Disease	MESH:D000544
38182581	242	259	cognitive decline	Disease	MESH:D003072
38182581	305	324	Alzheimer's disease	Disease	MESH:D000544
38182581	326	328	AD	Disease	MESH:D000544
38182581	361	375	angiopoietin-1	Gene	284
38182581	377	384	ANGPT-1	Gene	284
38182581	413	427	angiopoietin-2	Gene	285
38182581	429	436	ANGPT-2	Gene	285
38182581	514	521	ANGPT-2	Gene	285
38182581	564	566	AD	Disease	MESH:D000544
38182581	619	621	AD	Disease	MESH:D000544
38182581	622	630	patients	Species	9606
38182581	707	709	AD	Disease	MESH:D000544
38182581	756	763	Abeta42	Gene	351
38182581	830	841	Alzheimer's	Disease	MESH:D000544
38182581	866	885	Alzheimer's Disease	Disease	MESH:D000544
38182581	981	983	AD	Disease	MESH:D000544
38182581	1011	1031	cognitive impairment	Disease	MESH:D003072
38182581	1033	1036	MCI	Disease	MESH:D060825
38182581	1051	1053	AD	Disease	MESH:D000544
38182581	1149	1156	ANGPT-2	Gene	285
38182581	1170	1177	albumin	Gene	213
38182581	1182	1192	fibrinogen	Gene	2244
38182581	1252	1259	ANGPT-2	Gene	285
38182581	1276	1278	AD	Disease	MESH:D000544
38182581	1330	1337	Abeta42	Gene	351
38182581	1339	1346	ANGPT-2	Gene	285
38182581	1398	1408	fibrinogen	Gene	2244
38182581	1477	1484	ANGPT-2	Gene	285
38182581	1500	1503	MCI	Disease	MESH:D060825
38182581	1528	1535	albumin	Gene	213
38182581	1550	1553	MCI	Disease	MESH:D060825
38182581	1573	1575	AD	Disease	MESH:D000544
38182581	1581	1588	ANGPT-2	Gene	285
38182581	1650	1665	neuronal injury	Disease	MESH:D009410
38182581	1667	1678	neurogranin	Gene	4900
38182581	1683	1698	alpha-synuclein	Gene	6622
38182581	1704	1721	neuroinflammation	Disease	MESH:D000090862
38182581	1723	1727	GFAP	Gene	2670
38182581	1732	1738	YKL-40	Gene	1116
38182581	1762	1769	ANGPT-2	Gene	285
38182581	1809	1816	albumin	Gene	213
38182581	1830	1837	ANGPT-2	Gene	285
38182581	1892	1899	ANGPT-2	Gene	285
38182581	1918	1925	albumin	Gene	213
38182581	1991	1998	ANGPT-2	Gene	285
38182581	2041	2043	AD	Disease	MESH:D000544
38182581	2070	2073	tau	Gene	4137
38182581	2088	2103	neuronal injury	Disease	MESH:D009410
38182581	2126	2133	ANGPT-2	Gene	285
38182581	2152	2162	BBB damage	Disease	MESH:C536830
38182581	2166	2168	AD	Disease	MESH:D000544
38182581	Association	MESH:D009410	285
38182581	Negative_Correlation	284	285
38182581	Association	MESH:D000090862	285
38182581	Positive_Correlation	MESH:D060825	285
38182581	Association	MESH:D009410	6622
38182581	Positive_Correlation	MESH:D000544	285
38182581	Association	285	4900

